JENNA ROBERTS: Open Payments
NPI 1245666809 · CROSBY, MN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$705 in 17 payments from 10 companies in 2025. Trend: 2023 $253 · 2024 $475 · 2025 $705
Food & beverage: $705
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 2 | $222 |
| Alnylam Pharmaceuticals Inc. | 1 | $146 |
| ABBVIE INC. | 2 | $87 |
| Novo Nordisk Inc | 3 | $79 |
| Lilly USA, LLC | 2 | $43 |
| Merck Sharp & Dohme LLC | 2 | $42 |
| PFIZER INC. | 2 | $31 |
| GlaxoSmithKline, LLC. | 1 | $23 |
| Exact Sciences Corporation | 1 | $17 |
| AstraZeneca Pharmaceuticals LP | 1 | $15 |
Products named: REPATHA, AMVUTTRA, MAVYRET, Wegovy, JARDIANCE, GARDASIL 9, PAXLOVID, UBRELVY.
Industry payments across MN — which companies pay providers there.
